Fulcrum Therapeutics, Inc. (FULC)
3.725
-0.02
(-0.67%)
USD |
NASDAQ |
Nov 18, 16:00
3.725
0.00 (0.00%)
After-Hours: 18:13
Fulcrum Therapeutics Price : 3.725 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.73 | 3.76 | 3.71 | 3.75 | 1.307M |
| Nov 16, 2026 | 3.77 | 3.77 | 3.70 | 3.71 | 1.642M |
| Nov 13, 2026 | 3.77 | 3.80 | 3.73 | 3.77 | 1.365M |
| Nov 12, 2026 | 3.74 | 3.74 | 3.68 | 3.68 | 2.139M |
| Nov 11, 2026 | 3.71 | 3.75 | 3.70 | 3.74 | 881425.0 |
| Nov 10, 2026 | 3.71 | 3.765 | 3.68 | 3.72 | 932214.0 |
| Nov 09, 2026 | 3.71 | 3.745 | 3.69 | 3.72 | 1.296M |
| Nov 06, 2026 | 3.67 | 3.73 | 3.67 | 3.70 | 891962.0 |
| Nov 05, 2026 | 3.77 | 3.775 | 3.67 | 3.68 | 1.637M |
| Nov 04, 2026 | 3.76 | 3.78 | 3.73 | 3.77 | 776314.0 |
| Nov 03, 2026 | 3.76 | 3.765 | 3.69 | 3.74 | 1.365M |
| Nov 02, 2026 | 3.72 | 3.725 | 3.64 | 3.65 | 1.214M |
| Oct 30, 2026 | 3.74 | 3.755 | 3.68 | 3.71 | 933217.0 |
| Oct 29, 2026 | 3.77 | 3.795 | 3.73 | 3.77 | 1.621M |
| Oct 28, 2026 | 3.69 | 3.77 | 3.67 | 3.75 | 1.998M |
| Oct 27, 2026 | 3.66 | 3.735 | 3.63 | 3.70 | 1.904M |
| Oct 26, 2026 | 3.69 | 3.69 | 3.63 | 3.64 | 773326.0 |
| Oct 23, 2026 | 3.68 | 3.69 | 3.64 | 3.68 | 1.067M |
| Oct 22, 2026 | 3.71 | 3.735 | 3.66 | 3.68 | 2.309M |
| Oct 21, 2026 | 3.72 | 3.745 | 3.70 | 3.70 | 923781.0 |
| Oct 20, 2026 | 3.71 | 3.75 | 3.695 | 3.72 | 757122.0 |
| Oct 19, 2026 | 3.67 | 3.72 | 3.66 | 3.70 | 1.195M |
| Oct 16, 2026 | 3.68 | 3.685 | 3.64 | 3.65 | 1.385M |
| Oct 15, 2026 | 3.71 | 3.725 | 3.66 | 3.67 | 1.226M |
| Oct 14, 2026 | 3.67 | 3.715 | 3.65 | 3.67 | 1.662M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.97 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0001 |
| Arvinas, Inc. | 6.77 |
| Definium Therapeutics, Inc. | 29.12 |
Price Related Metrics
| Price to Book Value | 0.9421 |
| Earnings Yield | -28.02% |
| Market Cap | 284.52M |